Pfizer Reports Declining Financial Metrics Amidst Improved Liquidity for Q4 2024

Jan 31 2025 08:31 PM IST
share
Share Via
Pfizer has reported its financial results for the quarter ending December 2024, revealing significant challenges. While the company achieved its highest cash and cash equivalents in recent periods, key performance indicators such as profit before tax, profit after tax, and net sales have all declined, indicating operational difficulties.
Pfizer, a prominent player in the Pharmaceuticals & Drugs industry, has recently reported its financial results for the quarter ending December 2024. The results indicate a challenging period for the company, with notable shifts in its financial metrics.

The evaluation changes reflect a significant decline in the overall score, which has dropped to -10 from 1 over the past three months. This adjustment in evaluation highlights the difficulties Pfizer is currently facing.

On a positive note, the company has reported its highest cash and cash equivalents in the last six half-yearly periods, amounting to Rs 2,281.32 crore, suggesting an improvement in short-term liquidity. However, several key performance indicators show concerning trends. Profit Before Tax less Other Income (PBT) has decreased to Rs 129.68 crore, marking an 18.2% decline compared to the average of the previous four quarters. Similarly, Profit After Tax (PAT) has fallen to Rs 127.60 crore, down 16.6% from prior averages.

Net sales have also reached their lowest point in five quarters at Rs 537.99 crore, while operating profit and operating profit margin have shown negative trends, indicating a decline in efficiency. Additionally, the earnings per share (EPS) have dropped to Rs 27.89, reflecting reduced profitability for shareholders. The debtors turnover ratio has also decreased, suggesting a slowdown in the company's ability to settle its debts.

Overall, Pfizer's recent financial results underscore a period of significant challenges and adjustments in its operational performance.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News